Petros Pharmaceuticals, Inc. Interest Payable, Current
Petros Pharmaceuticals, Inc. (PTPI) had Interest Payable, Current of $326.19 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2025-03-31
- 2024-12-31: Interest Payable, Current $326.19K.
- 2021-12-31: Interest Payable, Current $0.00.
- 2021-09-30: Interest Payable, Current $16.68K.
- 2021-06-30: Interest Payable, Current $32.83K.
| Period end | Interest Payable, Current |
|---|---|
| 2024-12-31 | $326.19K 10-K · filed 2025-03-31 |
| 2021-12-31 | $0.00 10-Q · filed 2022-08-12 |
| 2021-09-30 | $16.68K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $32.83K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $50.12K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $65.89K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |